Genomic instability is associated with lack of telomerase activation in ovarian cancer

Cancer Biology and Therapy

Volumn 3, Issue 12, 2004, Pages 1250-1253

  Landen, Charles N ^a   Klingelhutz, Al ^b   Coffin, Jeremy E ^b   Sorosky, Joel I ^a   Sood, Anil K ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

hTERT; Microsatellite instability; Ovarian cancer; Telomerase

Indexed keywords

RNA; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; DNA BINDING PROTEIN; MICROSATELLITE DNA; TELOMERASE RNA;

ARTICLE; CANCER INVASION; CHI SQUARE TEST; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SUBUNIT; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; MICROSATELLITE INSTABILITY; MICROSATELLITE MARKER; OVARY CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAMPLE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TUMOR; ENZYMOLOGY; FEMALE; GENETICS; METABOLISM; OVARY TUMOR;

DNA-BINDING PROTEINS; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOMIC INSTABILITY; HUMANS; MICROSATELLITE REPEATS; OVARIAN NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, NEOPLASM; TELOMERASE;

EID: 20444436493     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.3.12.1235     Document Type: Article

References (34)

1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100:57-70.
2. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990; 345:458-00.
3. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990; 346:866-8.
4. Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 1995; 14:4240-8.
5. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin, GB, et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998; 279:349-52.
6. Vaziri, H. and Benchimol, S. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr Biol, 8: 279-282, 1998.
7. Counter CM, Hirte HW, Bacchetti S, Harley CB. Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 1994; 91:2900-4.
8. Bryan TM, Marusic L, Bacchetti S, Namba M, Reddel RR. The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit. Hum Mol Genet 1997; 6:921-6.
9. Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Mecklin JP, et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993; 260:812-6.
10. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, et al. National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of micro satellite instability in colorectal cancer. Cancer Res 1998; 58:5248-57.
11. Sood AK, Holmes R, Hendrix MJ, Buller RE. Application of the National Cancer Institute international criteria for determination of microsatellite instability in ovarian cancer. Cancer Res 2001; 61:4371-4.
12. Arzimanoglou II, Lallas T, Osborne M, Barber H, Gilbert F. Microsatellite instability differences between familial and sporadic ovarian cancers. Carcinogenesis 1996; 17:1799-804.
13. Kyo S, Kanaya T, Ishikawa H, Ueno H, Inoue M. Telomerase activity in gynecological tumors. Clin Cancer Res 1996; 2:2023-8.
14. Sood AK, Buller RE. Genomic instability in ovarian cancer: a reassessment using an arbitrarily primed polymerase chain reaction. Oncogene 1996; 13:2499-504.
15. Rizki A, Lundblad V. Defects in mismatch repair promote telomerase-independent proliferation. Nature 2001; 411:713-6.
16. Rohde V, Sattler HP, Bund T, Bonkhoff H, Fixemer T, Bachmann C, et al. Expression of the human telomerase reverse transcriptase is not related to telomerase activity in normal and malignant renal tissue. Clin Cancer Res 2000; 6:4803-9.
17. Boland CR, Sato J, Saito K, Carethers JM, Marra G, Laghi L, et al. Genetic instability and chromosomal aberrations in colorectal cancer: a review of the current models. Cancer Detect Prev 1998; 22:377-82.
18. Skilling JS, Squatrito RC, Connor JP, Niemann T, Buller RE. p53 gene mutation analysis and antisense-mediated growth inhibition of human ovarian carcinoma cell lines. Gynecol Oncol 1996; 60:72-80.
19. Park TW, Riethdorf S, Riethdorf L, Loning T, Janicke F. Differential telomerase activity, expression of the telomerase catalytic sub-unit and telomerase-RNA in ovarian tumors. Int J Cancer 1999; 84:426-31.
20. Kyo S, Takakura M, Tanaka M, Murakami K, Saitoh R, Hirano H, et al. Quantitative differences in telomerase activity among malignant, premalignant, and benign ovarian lesions. Clin Cancer Res 1998; 4:399-405.
21. Sood AK, Coffin J, Jabbari S, Buller RE, Hendrix MJ, Klingelhutz A. p53 null mutations are associated with a telomerase negative phenotype in ovarian carcinoma. Cancer Biol Ther 2002; 1:511-7.
22. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 1997; 3:1271-4.
23. Reddel RR. Alternative lengthening of telomeres, telomerase, and cancer. Cancer Lett 2003; 194:155-62.
24. Perrem K, Colgin LM, Neumann AA, Yeager TR, Reddel RR. Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells. Mol Cell Biol 2001; 21:3862-75.
25. Cerone MA, Londono-Vallejo JA, Bacchetti S. Telomere maintenance by telomerase and by recombination can coexist in human cells. Hum Mol Genet 2001; 10:1945-52.
26. Bechter OE, Zou Y, Walker W, Wright WE, Shay JW. Telomeric recombination in mismatch repair deficient human colon cancer cells after telomerase inhibition. Cancer Res 2004; 64:3444-51.
27. Fishman-Lobell J, Haber JE. Removal of nonhomologous DNA ends in double-strand break recombination: the role of the yeast ultraviolet repair gene RAD1. Science 1992; 258:480-4.
28. de Caceres II, Frolova N, Varkonyi RJ, Dulaimi E, Meropol NJ, Broccoli D, et al. Telomerase is frequently activated in tumors with microsatellite instability. Cancer Biol Ther 2004; 3:289-92.
29. Kyo S, Kanaya T, Takakura M, Tanaka M, Yamashita A, Inoue H, et al. Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors. Int J Cancer 1999; 80:804-9.
30. Ulaner GA, Hu JF, Vu TH, Oruganti H, Giudice LC, Hoffman AR. Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium. Int J Cancer 2000; 85:330-5.
31. Braunstein I, Cohen-Barak O, Shachaf C, Ravel Y, Yalon-Hacohen M, Mills GB, et al. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells. Cancer Res 2001; 61:5529-36.
32. Blasco MA. Telomerase beyond telomeres. Nat Rev Cancer 2002; 2:627-33.
33. Liu JP. Studies of the molecular mechanisms in the regulation of telomerase activity. Faseb J 1999; 13:2091-104.
34. Stewart SA, Hahn WC, O'Connor BF, Banner EN, Lundberg AS, Modha P, et al. Telomerase contributes to tumorigenesis by a telomere length-independent mechanism. Proc Natl Acad Sci 2002; 99:12606-11.